Literature DB >> 19923134

Small temperature variations alter edaravone-induced neuroprotection of cortical cultures exposed to prolonged hypoxic episodes.

S Shibuta1, S Varathan, T Kamibayashi, T Mashimo.   

Abstract

BACKGROUND: Edaravone, a free radical scavenger, has been shown to be neuroprotective in vivo and in vitro. However, the impact of small temperature variations on its neuroprotective actions remains unknown.
METHODS: We examined the degree of neuroprotection conferred by various concentrations of edaravone on cortical cultures exposed to prolonged hypoxia (24 h) under three conditions: mild hypothermia (32 degrees C), normothermia (37 degrees C), and mild hyperthermia (39 degrees C). The survival of cortical neurones from E16 Wistar rats (SR) was evaluated using photomicrographs taken before and after exposure to hypoxia.
RESULTS: The mean survival of neurones exposed to hypoxia at normothermia was 14.7 (sem 1.8)%. The addition of 50 microM edaravone significantly improved the mean survival to 40.5 (4.7)%. This improvement was noted at higher doses of edaravone (5 microM < or =) but not at lower doses (< or =500 nM). With mild hypothermia and prolonged hypoxia without edaravone, neuroprotection was significantly improved with a mean survival of 63.0 (5.2)%. This neuroprotective effect was not enhanced with the addition of edaravone, even at the highest dose. Hypoxia-induced neurotoxicity was aggravated by mild hyperthermia as reflected by a mean survival of 9.1 (2.1)%. However, higher concentrations of edaravone inhibited the deleterious effect of mild hyperthermia, thereby demonstrating a significant neuroprotective effect. The survival of neurones subjected to both hyperthermia and edaravone was the same as that of neurones exposed to normothermia and edaravone.
CONCLUSIONS: Temperature is a potential factor in determining whether edaravone confers a neuroprotective effect when applied during prolonged hypoxic insults.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19923134     DOI: 10.1093/bja/aep320

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

Review 1.  Perinatal hypoxic-ischemic damage: review of the current treatment possibilities.

Authors:  A Frajewicki; Z Laštůvka; V Borbélyová; S Khan; K Jandová; K Janišová; J Otáhal; J Mysliveček; V Riljak
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

2.  Protective effects of combined treatment with mild hypothermia and edaravone against cerebral ischemia/reperfusion injury via oxidative stress and Nrf2 pathway regulation.

Authors:  Hang Yu; Zhidian Wu; Xiaozhi Wang; Chang Gao; Run Liu; Fuxin Kang; Mingming Dai
Journal:  Int J Oncol       Date:  2020-06-04       Impact factor: 5.650

3.  Effect of preconditioning on propofol-induced neurotoxicity during the developmental period.

Authors:  Satoshi Shibuta; Tomotaka Morita; Jun Kosaka
Journal:  PLoS One       Date:  2022-08-19       Impact factor: 3.752

4.  Antioxidant Enzyme-Mimetic Activity and Neuroprotective Effects of Cerium Oxide Nanoparticles Stabilized with Various Ratios of Citric Acid and EDTA.

Authors:  Ana Y Estevez; Mallikarjunarao Ganesana; John F Trentini; James E Olson; Guangze Li; Yvonne O Boateng; Jennifer M Lipps; Sarah E R Yablonski; William T Donnelly; James C Leiter; Joseph S Erlichman
Journal:  Biomolecules       Date:  2019-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.